Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| AZN.L | +2.98% | +8.86% | +12.16% | +13.68% | +10.48% | +0.76% | +13.19% | +45.07% | +54.76% |
| SCBIHEALT(SSFE) | +12.60% | +3.34% | +6.78% | +8.27% | +11.10% | +23.33% | +17.20% | +28.90% | −1.84% |
| SCBGHCA | +10.67% | +2.27% | +5.01% | +6.41% | +3.72% | +14.55% | +19.95% | +46.48% | +46.51% |
| BCARERMF | +15.33% | +1.81% | +5.38% | +6.86% | +7.46% | +18.07% | +23.62% | +35.92% | +29.83% |
| KFHEALTH-D | +18.72% | +3.10% | +5.57% | +8.69% | +7.73% | +21.65% | +22.37% | +31.70% | +29.05% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes AZN.L: money market or bond funds, or no holdings data yet
| SCBGHCA | KFHEALTH-D | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 9.72% | 7.92% |
 Johnson & Johnson | 7.87% | 6.24% |
 ABBVIE | 4.99% | 7.23% |
 AstraZeneca | 3.75% | 4.06% |
 Thermo Fisher | 3.39% | 4.56% |
 Unitedhealth Group | 4.32% | 3.27% |
 Novartis | 2.76% | 4.46% |
 Merck & | 2.38% | 5.25% |
| Only in SCBGHCA | ||
 Roche | 2.71% | N/A |
 argenx | 2.48% | N/A |
| Only in KFHEALTH-D | ||
 Abbott Laboratories | N/A | 2.87% |
 Danaher | N/A | 2.87% |
30 Dec 2025 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| KFHEALTH-D | +18.72% | 16.36% | 1.14 |
| BCARERMF | +15.33% | 16.01% | 0.96 |
| SCBIHEALT(SSFE) | +12.60% | 17.46% | 0.72 |
| SCBGHCA | +10.67% | 16.91% | 0.63 |
| AZN.L | +2.98% | 29.51% | 0.10 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | AZN.L | SCBIHEALT(SSFE) | SCBGHCA | BCARERMF | KFHEALTH-D |
|---|---|---|---|---|---|
Fund details | |||||
| Fund size | N/A | 10.22 million | 958 million | 8,627 million | 2,984 million |
| Inception date | N/A | 29 Jun 2021 | 2 Sep 2015 | 19 May 2015 | 1 Aug 2014 |
| Master fund | N/A | BNP Paribas Funds Health Care Innovators | Janus Henderson Global Life Sciences Fund | Wellington Global Health Care Equity Fund | JPMorgan Funds - Global Healthcare Fund |
| Dividend policy | N/A | Pays | Does not pay | Does not pay | Pays |
Risk and currency hedging | |||||
| Risk level | N/A | 7 | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Almost fully hedged | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 82.39% | 100.09% | 45.53% | 0.00% |
Minimum purchase and redemption | |||||
| First purchase | N/A | 1 THB | 1 THB | 500 THB | 500 THB |
| Subsequent purchase | N/A | 1 THB | 1 THB | 500 THB | 500 THB |
| Redemption (amount) | N/A | No minimum | 1 THB | No minimum | 500 THB |
| Redemption (units) | N/A | No minimum | No minimum | No minimum | 50 units |
| Balance (amount) | N/A | No minimum | 1 THB | No minimum | No minimum |
| Balance (units) | N/A | No minimum | No minimum | No minimum | 50 units |
Order cut-off and redemption payment | |||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 | 14:30 |
| Redemption paid | N/A | T+4 | T+5 | T+4 | T+4 |
